Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis

ClinicalTrials.gov ID: NCT00597584

Public ClinicalTrials.gov record NCT00597584. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AFX01-14: A Phase 3, Randomized, Active-controlled, Open-label, Multi-center Study of the Safety and Efficacy of Peginesatide for the Maintenance Treatment of Anemia in Hemodialysis Patients Previously Treated With Epoetin

Study identification

NCT ID
NCT00597584
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Affymax
Industry
Enrollment
823 participants

Conditions and interventions

Interventions

  • peginesatide Drug
  • Epoetin alfa or Epoetin beta Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2007
Primary completion
Jun 30, 2009
Completion
Dec 31, 2009
Last update posted
Mar 7, 2013

2007 – 2010

United States locations

U.S. sites
39
U.S. states
20
U.S. cities
36
Facility City State ZIP Site status
Research Facility Phoenix Arizona 85012
Research Facility Hot Springs Arkansas 71901
Research Facility McGehee Arkansas 71654
Research Facility Pine Bluff Arkansas 71603
Research Facility Bakersfield California 93309
Research Facility Glendale California 91205
Research Facility Los Angeles California 90033
Research Facility Los Angeles California 90048
Research Facility Los Angeles California 90073
Research Facility Riverside California 92505
Research Facility Simi Valley California 93065
Research Facility Whittier California 90602
Research Facility Yuba City California 95991
Research Facility Westminster Colorado 80031
Research Facility Lauderdale Lakes Florida 33313
Research Facility Miami Florida 33173
Research Facility Pinecrest Florida 33156
Research Facility Flossmoor Illinois 60422
Research Facility Hines Illinois 60141
Research Facility Louisville Kentucky 40202
Research Facility Rockville Maryland 20850
Research Facility Springfield Massachusetts 01107
Research Facility Detroit Michigan 48202
Research Facility Detroit Michigan 48236
Research Facility Brookhaven Mississippi 39601
Research Facility Brooklyn New York 11238
Research Facility Flushing New York 11355
Research Facility The Bronx New York 10461
Research Facility Asheville North Carolina 28801
Research Facility Toledo Ohio 43606
Research Facility Oklahoma City Oklahoma 73116
Research Facility Erie Pennsylvania 16507
Research Facility Philadelphia Pennsylvania 19141
Research Facility Providence Rhode Island 02904
Research Facility Orangeburg South Carolina 29118
Research Facility Arlington Texas 76015
Research Facility Houston Texas 77099
Research Facility San Antonio Texas 78215
Research Facility Fairfax Virginia 22033

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00597584, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 7, 2013 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00597584 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →